Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 22, 2008
[Treatment of malignant effusions with the injection of dendritic cells derived from autologous peripheral CD34+ stem cells]Li-jun Di, Jun Ren, Guo-hong Song, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 18, 2008
[Expression of genes related to Sonic Hedgehog signaling in human hepatocellular carcinomas]Li Che, Jun Ren, Yan Hua Yuan, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 20, 2011
[Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line]Xiao-li Wang, Bo Ma, Jun Jia, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 8, 2013
Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer PatientsJing Yu, Jun Ren, Li-Jun Di, et al.
Breast (Edinburgh, Scotland)|February 4, 2017
Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patientsXiao-Ran Liu, Bin Shao, Jia-Xi Peng, et al.
Oncotarget|October 14, 2015
The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusionQing-Kun Song, Jun Ren, Xin-Na Zhou, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 16, 2011
[Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer]Jing Yu, Li jun DI, Guo hong Song, et al.
Breast (Edinburgh, Scotland)|December 9, 2020
Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancerXiao-Ran Liu, Jian-Jun Yu, Guo-Hong Song, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|April 17, 2018
[Bushen Daozhuo Granules for type Ⅲ prostatitis: A multicenter randomized controlled clinical trial]Da-Lin Sun, Bin Cai, Bao-Fang Jin, et al.
Technology in Cancer Research & Treatment|March 5, 2020
Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast CancerXiao-Ran Liu, Ru-Yan Zhang, Hao Gong, et al.
Pageof 3